Duchenne UK grants £86,460 to further understand the causes of heart disease in DMD

Duchenne UK has granted £86,460 to Dr John Bourke at Newcastle Hospital, to carry out a study of Arrhythmias to improve understanding of the causes of heart disease in DMD.Read more

Taurine Project Q&A

We recently awarded £273,648 to the University of Western Australia to investigate Taurine as a treatment for Duchenne muscular dystrophy. We have put together a short Q&A to explain why we are excited about this project and what it could mean for the Duchenne community.Read more

Fibrosis Project Q&A

We recently announced £82,405 funding to investigate the development of a potential new test system for drugs that impact fibrosis in DMD. We have put together a short Q&A to explain why this project is so important and what it could bring to the Duchenne community.Read more

Duchenne UK commits $162,600 to support the development of a novel, minimally invasive biomarker to estimate lean muscle mass

Duchenne UK is pleased to be supporting this collaboration to look at developing biomarkers that may have the ability to help measure muscle health through blood and urine.Read more

Newcastle Information Day September 2018

On Saturday 22nd September 23 hosted our third FREE Parent and Caregiver Information Day, in Newcastle. The presentations from the day are now available to download at home.Read more

Summary of paper published: Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug

Positive results have been released from the first in-patient clinical study of vamorolone, a trial part funded by Duchenne UK.Read more

Duchenne UK grants £82,405 to investigate the development of a potential new test system for drugs that impact fibrosis in DMD

Duchenne UK is granting £82,405 to Dr Lee Borthwick and Professor Derek Mann at Newcastle University to develop a new test of potential medicines to treat fibrosis in DMD.Read more

New insights into muscle fibre loss in Duchenne muscular dystrophy

Professor Jenny Morgan and her team at UCL have shown that a type of cell death called necroptosis has an important role in Duchenne muscular dystrophy. This study helps improve our understanding of muscle fibre loss in Duchenne muscular dystrophyRead more

Updated Family Guide for DMD

n line with the three articles about care considerations for DMD recently published in Lancet Neurology1-3, a new Duchenne Guide for Families has been developed and will be launched online on World Duchenne Awareness Day, September 7, 2018.Read more

Study by RVC demonstrates potential of using gene therapy technology to treat DMD

The study, has succeeded in using gene editing techniques on dogs to restore the expression of the dystrophin protein that is absent in DMD patients’ muscles to levels that could be life changing.Read more